Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 3
1986 3
1987 4
1988 2
1990 5
1991 1
1992 3
1994 4
1995 3
1996 5
1997 2
1998 3
1999 9
2000 6
2001 1
2002 4
2003 4
2004 2
2005 7
2006 9
2007 6
2008 6
2009 11
2010 15
2011 14
2012 11
2013 20
2014 20
2015 12
2016 14
2017 16
2018 11
2019 19
2020 12
Text availability
Article attribute
Article type
Publication date

Search Results

226 results
Results by year
Filters applied: . Clear all
Page 1
Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial.
Smith MR, Saad F, Coleman R, Shore N, Fizazi K, Tombal B, Miller K, Sieber P, Karsh L, Damião R, Tammela TL, Egerdie B, Van Poppel H, Chin J, Morote J, Gómez-Veiga F, Borkowski T, Ye Z, Kupic A, Dansey R, Goessl C. Smith MR, et al. Among authors: morote j. Lancet. 2012 Jan 7;379(9810):39-46. doi: 10.1016/S0140-6736(11)61226-9. Epub 2011 Nov 15. Lancet. 2012. PMID: 22093187 Free PMC article. Clinical Trial.
Denosumab and bone metastasis-free survival in men with nonmetastatic castration-resistant prostate cancer: exploratory analyses by baseline prostate-specific antigen doubling time.
Smith MR, Saad F, Oudard S, Shore N, Fizazi K, Sieber P, Tombal B, Damiao R, Marx G, Miller K, Van Veldhuizen P, Morote J, Ye Z, Dansey R, Goessl C. Smith MR, et al. Among authors: morote j. J Clin Oncol. 2013 Oct 20;31(30):3800-6. doi: 10.1200/JCO.2012.44.6716. Epub 2013 Sep 16. J Clin Oncol. 2013. PMID: 24043751 Free PMC article. Clinical Trial.
Systematic review of renal carcinoma prognostic factors.
Lorente D, Trilla E, Meseguer A, Planas J, Placer J, Celma A, Salvador C, Regis L, Morote J. Lorente D, et al. Among authors: morote j. Actas Urol Esp. 2017 May;41(4):215-225. doi: 10.1016/j.acuro.2016.08.003. Epub 2016 Sep 20. Actas Urol Esp. 2017. PMID: 27659130 Review. English, Spanish.
Early continence after radical prostatectomy: A systematic review.
Salazar A, Regis L, Planas J, Celma A, Díaz F, Gallardo I, Trilla E, Morote J. Salazar A, et al. Among authors: morote j. Actas Urol Esp. 2019 Dec;43(10):526-535. doi: 10.1016/j.acuro.2019.06.003. Epub 2019 Oct 10. Actas Urol Esp. 2019. PMID: 31606163 English, Spanish.
Performance of the Bladder EpiCheck™ Methylation Test for Patients Under Surveillance for Non-muscle-invasive Bladder Cancer: Results of a Multicenter, Prospective, Blinded Clinical Trial.
Witjes JA, Morote J, Cornel EB, Gakis G, van Valenberg FJP, Lozano F, Sternberg IA, Willemsen E, Hegemann ML, Paitan Y, Leibovitch I. Witjes JA, et al. Among authors: morote j. Eur Urol Oncol. 2018 Sep;1(4):307-313. doi: 10.1016/j.euo.2018.06.011. Epub 2018 Jul 17. Eur Urol Oncol. 2018. PMID: 31100252 Free article. Clinical Trial.
Targeting fibroblast growth factor receptors and immune checkpoint inhibitors for the treatment of advanced bladder cancer: New direction and New Hope.
Morales-Barrera R, Suárez C, de Castro AM, Racca F, Valverde C, Maldonado X, Bastaros JM, Morote J, Carles J. Morales-Barrera R, et al. Among authors: morote j. Cancer Treat Rev. 2016 Nov;50:208-216. doi: 10.1016/j.ctrv.2016.09.018. Epub 2016 Oct 1. Cancer Treat Rev. 2016. PMID: 27743530 Review.
Are targeted prostate biopsies ready to replace systematic prostate biopsies?
Celma A, López R, Roche S, Planas J, Regis L, Placer J, Borque A, Esteban LM, de Torres I, Morote J. Celma A, et al. Among authors: morote j. Actas Urol Esp. 2019 Dec;43(10):573-578. doi: 10.1016/j.acuro.2018.06.011. Epub 2019 Oct 31. Actas Urol Esp. 2019. PMID: 31679807 English, Spanish.
Reversal Unilateral Ureteral Obstruction: A Mice Experimental Model.
Narváez Barros A, Guiteras R, Sola A, Manonelles A, Morote J, Cruzado JM. Narváez Barros A, et al. Among authors: morote j. Nephron. 2019;142(2):125-134. doi: 10.1159/000497119. Epub 2019 Feb 15. Nephron. 2019. PMID: 30783029
siRNA-silencing of CD40 attenuates unilateral ureteral obstruction-induced kidney injury in mice.
Narváez A, Guiteras R, Sola A, Manonelles A, Morote J, Torras J, Grinyó JM, Cruzado JM. Narváez A, et al. Among authors: morote j. PLoS One. 2019 Apr 12;14(4):e0215232. doi: 10.1371/journal.pone.0215232. eCollection 2019. PLoS One. 2019. PMID: 30978213 Free PMC article.
Comparison of standard vs. palliative management for bladder cancer in patients older than 85 years: multicenter study of 317 de novo tumors.
Carrion A, Huguet J, Ribal MJ, Domínguez A, Bonet X, Servián P, Mayordomo O, Ajami T, Picola N, Freixa R, Díaz F, Lozano F, Raventós C, Morote J. Carrion A, et al. Among authors: morote j. Urol Oncol. 2020 Feb;38(2):40.e9-40.e15. doi: 10.1016/j.urolonc.2019.09.007. Epub 2019 Oct 2. Urol Oncol. 2020. PMID: 31586544
226 results
Jump to page
Feedback